Finance

Lists
CHE:NYSE
Chemed Corp
$499.70
-0.86%
(-4.36) 1D
Sep 21, 11:47:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHE...
Open
$507.79
High
$509.59
Low
$498.99
Mkt. cap
6.53B
Avg. vol.
150.77K
Volume
21.73K
Dividend
0.56%
Quarterly dividend
$0.70
Ex-dividend date
Aug 17, 2026
P/E ratio
25.09
52-wk high
$557.00
52-wk low
$365.20
EPS
$19.92
Beta
0.51
Shares outstanding
13.07M
No. of employees
16K
Open
$507.79
High
$509.59
Low
$498.99
Mkt. cap
6.53B
Avg. vol.
150.77K
Volume
21.73K
Dividend
0.56%
Quarterly dividend
$0.70
Ex-dividend date
Aug 17, 2026
P/E ratio
25.09
52-wk high
$557.00
52-wk low
$365.20
EPS
$19.92
Beta
0.51
Shares outstanding
13.07M
No. of employees
16K
News stories
From web sources and news partners
About Chemed Corp
CEOKevin J Mcnamara
Employees15.8K
Founded1970
HeadquartersCincinnati, Ohio, United States
SectorHealth care provider
Websitechemed.com
Analyst ratings
Based on 3 analysts giving stock ratings to CHE in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CHE in the last 3 months.
Highest
Current $499.70
$590.00 (+18.07%)
Average
$562.67 (+12.60%)
Lowest
$548.00 (+9.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanna Gajuk
Bank of America Securities
Hold
Maintained
$550.00
+10.1%
09/16/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$590.00
+18.1%
07/31/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$548.00
+9.7%
07/30/2026
Brian Tanquilut
Jefferies
Hold
Maintained
$400.00
-20%
02/26/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$6.06 / $5.60
+8.21%beat
Revenue / Est. (USD)
673.25M / 665.04M
+1.24%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
624.90M
639.34M
657.51M
673.25M
Cost of goods sold
427.99M
414.17M
441.75M
451.78M
Cost of revenue
427.99M
414.17M
441.75M
451.78M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.78M
102.80M
114.32M
115.20M
Operating expense
122.16M
118.91M
131.19M
132.27M
Total operating expenses
550.15M
533.07M
572.94M
584.05M
Operating income
74.75M
106.26M
84.58M
89.20M
Other non operating income
6.70M
3.75M
3.88M
3.70M
EBT including unusual items
83.54M
105.44M
88.84M
91.33M
EBT excluding unusual items
83.54M
111.05M
88.84M
91.33M
Income tax expense
19.31M
28.69M
22.54M
23.63M
Effective tax rate
23.11%
27.21%
25.37%
25.87%
Other operating expenses
148.00K
-225.00K
-8.00K
78.00K
Net income
64.24M
76.75M
66.30M
67.70M
Net profit margin
10.28%
12.00%
10.08%
10.06%
Earnings per share
5.27
6.42
5.65
6.06
Interest and investment income
2.56M
1.56M
890.00K
214.00K
Interest expense
-457.00K
-521.00K
-512.00K
-1.79M
Net interest expenses
2.10M
1.04M
378.00K
-1.58M
Depreciation and amortization charges
13.66M
13.76M
14.30M
14.27M
EBITDA
90.98M
118.29M
101.45M
106.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps